
By BY KENNETH CHANG from NYT Health https://ift.tt/3qSjJoY




Respiratory specialists failed to block the Philip Morris acquisition of inhaler manufacturer Vectura. Now they are banding together to exclude tobacco-owned businesses from pulmonary research.